Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reef boundary layers and macroalgae untargeted metabolomics

ABSTRACT: Untargeted metabolomics (LC-MS/MS) of water samples (SPE on Strata XL Phenomonex) and of macroalgal whole tissues (50% MeOH/DCM) and surface extracts (MeOH). Positive and negative ionization mode

INSTRUMENT(S): Q Exactive Plus

ORGANISM(S): Turbinaria Ornata (ncbitaxon:86657) Dictyota Bartayresiana (ncbitaxon:672008) Environmental Samples <bacillariophyta> (ncbitaxon:33858)

SUBMITTER: Chloe Pozas-Schacre

PROVIDER: MSV000091424 | MassIVE | Tue Mar 07 06:46:00 GMT 2023

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Coral multiomic response to macroalgal competition

Project description:Untargeted metabolomics (LC-MS/MS) of coral whole extracts (50% MeOH/DCM) and of coral seawater samples (SPE on Strata X, Phenomonex). Positive ionization mode. Corals were exposed to direct and indirect contact with the macroalgae Dictyota bartayresiana

2025-02-04 | MSV000097038 | MassIVE

untargeted metabolomics of bauxite residue

Project description:untargeted metabolomics of bauxite residue Raw sequence reads

| PRJNA1132932 | ENA

GNPS - Coral multiomic response to macroalgal competition

2025-02-04 | MSV000097038 | GNPS

fractionated_extractions_JB182_qTOF_Fractions_D_E_F

Project description:Glutamicibacter arilaitensis grown in large scale liquid Cheese Curd media and extracted with Amberlite XAD16, back extracted with MeOH:DCM 50:50, separated on SPE column to afford 7 fractions labeled A through G based on increasing polarity (A = 10% MeOH, F = 100% MeOH and G = 100% EtoAC. Fractions E(60% MeOH), D(80% MeOH), and F(100% MeOH) run on a qTOF and submitted here. suffix 1 refers to treatment of cultures with desferrioxamine and suffix PLAIN means untreated. JB182new_20170614 is a crude extract from a subsequent small scale growup without desferrioxamine.

2019-04-18 | MSV000083701 | MassIVE

Immune-Metabolic Regulation of Early Osseointegration: Insights from Untargeted RNA Sequencing

Project description:This study clarified how implant surfaces influence early osseointegration by coupling untargeted RNA sequencing with histomorphometry. Four rabbits each received three tibial implants: turned commercially pure titanium (Ti), sandblasted/large-grit/acid-etched titanium (SLA-Ti), and turned copper (Cu). Surface morphology was characterized by scanning electron microscopy, confocal microscopy, and energy dispersive spectroscopy. After 10 days, bone-to-implant contact (BIC), bone area (BA), and peri-implant transcriptomes were analyzed. Differentially expressed genes and Gene ontology (GO) enrichment were computed. SLA-Ti showed the greatest roughness. Both Ti groups yielded significantly higher BIC and BA than Cu (p < 0.001). GO terms on SLA-Ti were enriched for immune regulation and turned Cu was dominated by mitochondrial-stress pathways. Turned Ti showed minimal enrichment. SLA-Ti simultaneously up-regulated pro-inflammatory cytokines and immunoregulatory genes plus stress-adaptive markers, suggesting a balanced inflammatory milieu conducive to bone formation. Turned Cu markedly elevated mitochondrial genes and oxidative-stress markers, while suppressing antioxidant and innate-defense genes, reflecting immune-metabolic dysregulation. Turned Ti induced only modest transcript changes, consistent with passive biocompatibility. Early osseointegration hinges on a finely tuned immune-metabolic equilibrium rather than surface roughness alone. Optimal integration demands implant surfaces that trigger controlled immunomodulation while limiting oxidative stress, guiding the design of next-generation dental implants.

2025-06-10 | GSE299424 | GEO

GNPS_GC_ProspecTER_Sponge_Fmd_20250505_Yunhai Li

Project description:GC-MS profiling of fraction MeOH/DCM (1:1, v/v) of 29 sponge extracts from Irish waters. Freeze-dried sponges extracted by MeOH/DCM (1:1) and then fractionated by RP-SPE (1 g C18 stationary phase) into 4 fractions: H2O, H2O/MeOH (1:1), MeOH, MeOH/DCM (1:1).

2025-05-05 | MSV000097798 | GNPS

GNPS_GC_ProspecTER_Sponge_Fmd_20250506_Yunhai Li

2025-05-05 | MSV000097800 | GNPS

GNPS_GC_ProspecTER_Sponge (Fmd)_20250504_Yunhai Li

2025-05-04 | MSV000097792 | GNPS

Tear proteome analysis by LC-MS/MS

Project description:We have analysed the tear proteome from multiple volunteers without ocular disease using untargeted LC-MS/MS with and without pre-fractionation of peptide digests. Standard LC-MS/MS was compared to results from fractionation by mixed-mode cation exchange SPE and reverse-phase HPLC fractionation. The combined analysis of all these samples resulted in the identification of 886 proteins.

2023-09-01 | PXD041752 | Pride

RNA-Seq analysis of EZH2 mutants in isogenic cell lines

Project description:The Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) is an essential epigenetic modifier able to methylate lysine 27 on histone H3 (H3K27) to induce chromatin compaction, protein complex recruitment and ultimately transcriptional repression. Hematologic malignancies, including Diffuse Large B cell lymphoma (DLBCL) and Acute myeloid leukemia (AML) have shown a high EZH2-mutation frequency (>20%) associated with poor clinical outcomes. Particularly, two distinct oncogenic mutations, so-called gain-of-function (Y641F and A677G) and loss-of-function (H689A and F667I) are found in the catalytic domain of EZH2. In this study, a comprehensive multi-omics approach was employed to characterize downstream effects of H3K27me3 deposition driven by EZH2 mutations. Human embryonic kidney cells (HEK293T) were transfected to generate three stable EZH2 mutants: EZH2(Y641F), EZH2(A677G), and EZH2(H689A/F667I), which were validated via immunoblotting and DIA-MS-based histone profiling assay. Subsequently, constructs were analyzed under a comprehensive multi-omics approach including: 1) Cleavage Under Targets and Tagmentation (CUT&Tag); 2) chromatin accessibility characterization using the assay for transposase-accessible chromatin with sequencing (ATAC-Seq); 3) transcriptomics (RNA-Seq); 4) label-free whole-cell proteomics, acquired with a Bruker timsTOF Pro HPLC-MS/MS with Ion Mobility, and 5) MS-based untargeted metabolomics, in positive and negative ionization MS/MS mode, acquired with an Agilent 6545 QTOF with a 1290 UHPLC system and HILIC column. Total coverage comprised over 21,000 chromatin regions, 18,000 transcripts, 6,000 proteins and 400 metabolic features. Pair-wise comparison using univariate and supervised multivariate statistical methods revealed significant differences between constructs in each omic level. Furthermore, effector pathway analysis combining omics data revealed distinctive reprogramming effects for each EZH2 mutant.

2023-07-17 | GSE235013 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data